Finance

Lists
2637:HKG
Fujian Haixi Pharmaceuticals Co Ltd
HK$161,80
-0,86%
(-1,40) 1D
16 āš•.āšĨ., 16 āŧ‚āšĄāš‡ 8 āš™āšēāš—āšĩ 14 āš§āšīāš™āšēāš—āšĩ GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2637...
Open
HK$167,20
High
HK$167,20
Low
HK$159,70
Mkt. cap
12,73 āš•āš·āŧ‰
Avg. vol.
75,63 āšžāšąāš™
Volume
28,05 āšžāšąāš™
52-wk high
HK$302,40
52-wk low
HK$97,50
Shares outstanding
78,71 āšĨāŧ‰āšēāš™
No. of employees
200
Open
HK$167,20
High
HK$167,20
Low
HK$159,70
Mkt. cap
12,73 āš•āš·āŧ‰
Avg. vol.
75,63 āšžāšąāš™
Volume
28,05 āšžāšąāš™
52-wk high
HK$302,40
52-wk low
HK$97,50
Shares outstanding
78,71 āšĨāŧ‰āšēāš™
No. of employees
200
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
2 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Certain H Shares of Fujian Haixi Pharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 19-OCT-2026.
About Fujian Haixi Pharmaceuticals Co Ltd
CEO-
Employees200
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitehxpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
āšĄ.āš™. 2025
āšĄāšī.āš–. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
150,04 āšĨāŧ‰āšēāš™
150,04 āšĨāŧ‰āšēāš™
155,81 āšĨāŧ‰āšēāš™
155,81 āšĨāŧ‰āšēāš™
Cost of goods sold
20,31 āšĨāŧ‰āšēāš™
20,31 āšĨāŧ‰āšēāš™
28,23 āšĨāŧ‰āšēāš™
28,23 āšĨāŧ‰āšēāš™
Cost of revenue
20,31 āšĨāŧ‰āšēāš™
20,31 āšĨāŧ‰āšēāš™
28,23 āšĨāŧ‰āšēāš™
28,23 āšĨāŧ‰āšēāš™
Research and development expenses
13,56 āšĨāŧ‰āšēāš™
13,56 āšĨāŧ‰āšēāš™
20,38 āšĨāŧ‰āšēāš™
20,38 āšĨāŧ‰āšēāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,69 āšĨāŧ‰āšēāš™
55,69 āšĨāŧ‰āšēāš™
55,98 āšĨāŧ‰āšēāš™
55,98 āšĨāŧ‰āšēāš™
Operating expense
70,26 āšĨāŧ‰āšēāš™
70,26 āšĨāŧ‰āšēāš™
75,50 āšĨāŧ‰āšēāš™
75,50 āšĨāŧ‰āšēāš™
Total operating expenses
90,57 āšĨāŧ‰āšēāš™
90,57 āšĨāŧ‰āšēāš™
103,73 āšĨāŧ‰āšēāš™
103,73 āšĨāŧ‰āšēāš™
Operating income
59,47 āšĨāŧ‰āšēāš™
59,47 āšĨāŧ‰āšēāš™
52,07 āšĨāŧ‰āšēāš™
52,07 āšĨāŧ‰āšēāš™
Other non operating income
7,63 āšžāšąāš™
7,63 āšžāšąāš™
-8,03 āšĨāŧ‰āšēāš™
-8,03 āšĨāŧ‰āšēāš™
EBT including unusual items
61,44 āšĨāŧ‰āšēāš™
61,44 āšĨāŧ‰āšēāš™
42,15 āšĨāŧ‰āšēāš™
42,15 āšĨāŧ‰āšēāš™
EBT excluding unusual items
58,72 āšĨāŧ‰āšēāš™
58,72 āšĨāŧ‰āšēāš™
46,19 āšĨāŧ‰āšēāš™
46,19 āšĨāŧ‰āšēāš™
Income tax expense
7,54 āšĨāŧ‰āšēāš™
7,54 āšĨāŧ‰āšēāš™
1,63 āšĨāŧ‰āšēāš™
1,63 āšĨāŧ‰āšēāš™
Effective tax rate
12,27%
12,27%
3,86%
3,86%
Other operating expenses
873,16 āšžāšąāš™
873,16 āšžāšąāš™
-1,33 āšĨāŧ‰āšēāš™
-1,33 āšĨāŧ‰āšēāš™
Net income
53,90 āšĨāŧ‰āšēāš™
53,90 āšĨāŧ‰āšēāš™
40,52 āšĨāŧ‰āšēāš™
40,52 āšĨāŧ‰āšēāš™
Net profit margin
35,93%
35,93%
26,01%
26,01%
Earnings per share
-
-
-
-
Interest and investment income
919,46 āšžāšąāš™
919,46 āšžāšąāš™
3,96 āšĨāŧ‰āšēāš™
3,96 āšĨāŧ‰āšēāš™
Interest expense
-1,67 āšĨāŧ‰āšēāš™
-1,67 āšĨāŧ‰āšēāš™
-1,81 āšĨāŧ‰āšēāš™
-1,81 āšĨāŧ‰āšēāš™
Net interest expenses
-754,12 āšžāšąāš™
-754,12 āšžāšąāš™
2,15 āšĨāŧ‰āšēāš™
2,15 āšĨāŧ‰āšēāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
60,20 āšĨāŧ‰āšēāš™
60,20 āšĨāŧ‰āšēāš™
53,48 āšĨāŧ‰āšēāš™
53,48 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
āŧāš­āšąāššāš‚āš­āš‡ Google